» Articles » PMID: 34677455

Synthesis and Characterization of 2-Decenoic Acid Modified Chitosan for Infection Prevention and Tissue Engineering

Overview
Journal Mar Drugs
Publisher MDPI
Specialties Biology
Pharmacology
Date 2021 Oct 22
PMID 34677455
Authors
Affiliations
Soon will be listed here.
Abstract

Chitosan nanofiber membranes are recognized as functional antimicrobial materials, as they can effectively provide a barrier that guides tissue growth and supports healing. Methods to stabilize nanofibers in aqueous solutions include acylation with fatty acids. Modification with fatty acids that also have antimicrobial and biofilm-resistant properties may be particularly beneficial in tissue regeneration applications. This study investigated the ability to customize the fatty acid attachment by acyl chlorides to include antimicrobial 2-decenoic acid. Synthesis of 2-decenoyl chloride was followed by acylation of electrospun chitosan membranes in pyridine. Physicochemical properties were characterized through scanning electron microscopy, FTIR, contact angle, and thermogravimetric analysis. The ability of membranes to resist biofilm formation by and was evaluated by direct inoculation. Cytocompatibility was evaluated by adding membranes to cultures of NIH3T3 fibroblast cells. Acylation with chlorides stabilized nanofibers in aqueous media without significant swelling of fibers and increased hydrophobicity of the membranes. Acyl-modified membranes reduced both   and bacterial biofilm formation on membrane while also supporting fibroblast growth. Acylated chitosan membranes may be useful as wound dressings, guided regeneration scaffolds, local drug delivery, or filtration.

References
1.
Ferreira M, Lima I, Ribeiro A, Lobo A, Rizzo M, Osajima J . Biocompatible Gels of Chitosan-Buriti Oil for Potential Wound Healing Applications. Materials (Basel). 2020; 13(8). PMC: 7215912. DOI: 10.3390/ma13081977. View

2.
Moormeier D, Bayles K . Staphylococcus aureus biofilm: a complex developmental organism. Mol Microbiol. 2017; 104(3):365-376. PMC: 5397344. DOI: 10.1111/mmi.13634. View

3.
Azad A, Sermsintham N, Chandrkrachang S, Stevens W . Chitosan membrane as a wound-healing dressing: characterization and clinical application. J Biomed Mater Res B Appl Biomater. 2004; 69(2):216-22. DOI: 10.1002/jbm.b.30000. View

4.
Efiana N, Mahmood A, Lam H, Zupancic O, Leonaviciute G, Bernkop-Schnurch A . Improved mucoadhesive properties of self-nanoemulsifying drug delivery systems (SNEDDS) by introducing acyl chitosan. Int J Pharm. 2017; 519(1-2):206-212. DOI: 10.1016/j.ijpharm.2017.01.012. View

5.
Parker A, Jennings J, Bumgardner J, Courtney H, Lindner E, Haggard W . Preliminary investigation of crosslinked chitosan sponges for tailorable drug delivery and infection control. J Biomed Mater Res B Appl Biomater. 2012; 101(1):110-23. DOI: 10.1002/jbm.b.32822. View